id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-E-3555-0001,FDA,FDA-2024-E-3555,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T18:06:30Z,,0,0,090000648660d25e
FDA-2024-E-3555-0003,FDA,FDA-2024-E-3555,Requirement for Information,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T18:08:37Z,,0,0,090000648660d307
FDA-2024-E-3555-0002,FDA,FDA-2024-E-3555,"Patent Extension Application from Knobbe, Martens, Olson & Bear, LLP (on behalf of LimFlow GmbH (""LimFlow""))",Other,Application,2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T18:08:04Z,,0,0,090000648660d25f